Lonza Group AG
LONN
Rang în acțiuni
#447
Lonza Group AG, together with its subsidiaries, operates as a contract... Lonza Group AG, together with its subsidiaries, operates as a contract development and manufacturing organization for pharma and biotech companies in Europe, North and Central America, Latin America, Asia, Australia, New Zealand, and internationally. It operates through Integrated Biologics; Advanced Synthesis; and Specialized Modalities segments. The Integrated Biologics segment offers CDMO biologics services from clinical development, drug substance, and drug product manufacturing; and operates mammalian and drug product platforms. Its Advanced Synthesis segment manufactures antibody-drug conjugates (ADCs) and other bioconjugates, small molecules, and highly potent active pharmaceutical ingredients; and operates small molecules and bioconjugates platforms. The Specialized Modalities segment operates various technologies, such as spanning cell & gene, microbial, bioscience, and mRNA. Lonza Group AG was incorporated in 1897 and is headquartered in Basel, Switzerland.
Preț acțiune
$766.95
Capitalizare de piață
$53.57B
Schimbare (1 zi)
1.35%
Schimbare (1 an)
9.01%
Țară
CH
Tranzacționează Lonza Group AG (LONN)
Categorie
Healthcare
Istoricul spliturilor pentru Lonza Group AG (LONN)
Acțiunea Lonza Group AG (simbol: LONN) a trecut printr-un total de 0 splituri.
Cel mai recent split a avut loc pe Oct 22, 2026.
O acțiune LONN cumpărată înainte de Oct 22, 2026 este echivalentă astăzi cu 0 acțiuni LONN.
Cel mai recent split a avut loc pe Oct 22, 2026.
O acțiune LONN cumpărată înainte de Oct 22, 2026 este echivalentă astăzi cu 0 acțiuni LONN.
Listă splituri acțiuni
| An | Split | Multiplu | Multiplu cumulativ |
|---|---|---|---|
| Nu sunt suficiente date pentru perioada selectată. | |||
Splituri pentru companii similare sau competitori
| Companie | Număr total de splituri | Multiplu cumulativ | Țara |
|---|---|---|---|
| 1 | x2 |
US
|
|
| 0 | - |
US
|
|
| 1 | x3 |
AU
|
|
| 0 | - |
NL
|
|
| 1 | x100 |
BE
|
